547.06USD-0.98%Mkt Cap: 23.22B $P/E: 20.21Today
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationa…
Industry Peers
Drug Manufacturers - Specialty & Generic$66.02BUSDP/E 23.9
$18.95BUSD
$17.81BUSDP/E 27.2
$15.65BUSDP/E 179.2
$14.61BUSDP/E 30.6
$12.40BUSD
$8.81BUSDP/E 22.5
$7.96BUSD
$6.93BUSDP/E 458.4
$6.88BUSDP/E 25.2
$5.43BUSDP/E 46.0
$3.62BUSDP/E 18.9
$3.62BUSDP/E 11.6
$3.11BUSDP/E 21.7
$2.81BUSD
$2.66BUSDP/E 59.2
$2.66BUSD
$2.45BUSDP/E 17.0
$2.32BUSDP/E 12.5
$1.89BUSDP/E 19.2
$1.98BUSD
$1.73BUSD
$1.87BUSDP/E 21.0
$1.84BUSD
$1.51BUSDP/E 17.9
$1.58BUSD
$1.44BUSDP/E 119.1
$1.30BUSDP/E 13.8
$1.13BUSDP/E 35.5
$1.14BUSDP/E 17.1
$1.24BUSD
$1.08BUSD
$1.06BUSDP/E Infinity
$954.76MUSD
$1.00BUSD
$1.00BUSDP/E 196.0
$909.64MUSDP/E 39.7
$897.12MUSDP/E 14.4
$825.42MUSDP/E 11.3
$819.46MUSDP/E Infinity
$735.82MUSDP/E 7.2
$700.70MUSDP/E 163.3
$513.32MUSDP/E 14.5
$516.92MUSD
$462.55MUSD
$435.30MUSD
$447.39MUSD
$415.35MUSD
$375.56MUSD
$347.96MUSD
$319.75MUSDP/E 43.6
$308.82MUSD
$316.76MUSDP/E 10.1
$337.92MUSD
$293.86MUSDP/E 15.2
$278.44MUSDP/E 50.0
$287.37MUSD
$250.29MUSDP/E 47.6
$257.49MUSDP/E 12.8
$234.61MUSDP/E 52.6
$207.57MUSD
$194.14MUSDP/E 9.7
$190.26MUSD
$178.17MUSD
$177.48MUSDP/E 8.5
$174.12MUSD
$146.74MUSDP/E 18.7
$151.86MUSD
$130.47MUSD
$140.45MUSD
$120.89MUSD
$120.49MUSDP/E 18.7
$98.17MUSD
$84.56MUSDP/E 12.1
$88.85MUSD
$77.95MUSD
$74.40MUSD
$75.77MUSD
$65.95MUSDP/E 55.6
$65.40MUSD
$64.17MUSDP/E 22.0
$64.25MUSD
$57.58MUSD
$58.28MUSD
$53.33MUSD
$42.74MUSD
$46.21MUSD
$34.09MUSDP/E Infinity
$31.75MUSD
$31.25MUSD
$25.24MUSD
$24.15MUSD
$23.15MUSDP/E 200.0
$23.21MUSD
$22.14MUSD
$22.15MUSD
$17.93MUSD
$17.65MUSD
$14.93MUSD
$14.03MUSDP/E 17.1
$14.08MUSD
$12.18MUSD
$10.87MUSD
$10.99MUSD
$8.99MUSD
$8.90MUSD
$8.27MUSDP/E 0.3
$8.06MUSD
$6.48MUSDP/E 3.9
$6.29MUSD
$6.03MUSD
$5.08MUSDP/E Infinity
$3.29MUSDP/E 1.4
$1.87MUSD
$1.82MUSD
$1.71MUSDP/E 29.2
$1.54MUSD
$668.8KUSD
$207.6KUSDP/E 0.0
$175USD
Indicators:|
Key Statistics
Company
Market Cap23.22B $
Enterprise Value21.30B $
Revenue (TTM)3.17B $
Gross Profit2.80B $
Net Income (TTM)1.33B $
Revenue/Share72.12 USD
Last Price547.06 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees1.4K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINUS91307C1027
Valuation
P/E (Trailing)20.21
P/E (Forward)17.37
PEG2.22
EV/EBITDA13.75
EV/Revenue6.72
P/S7.40
P/B3.95
EPS (TTM)26.96
EPS (Forward)31.80
52W Range
272.1282% of range609.35
52W High609.35 USD
52W Low272.12 USD
Profitability
Gross Margin87.92%
Oper. Margin41.69%
EBITDA Margin48.85%
Profit Margin41.94%
ROE18.81%
ROA16.94%
Growth
Revenue Growth-1.60%
Earnings Growth-12.20%
Cash Flow & Leverage
Operating CF1.56B $
CapEx (TTM)526.00M $
FCF Margin17.87%
FCF Yield2.44%
Net Debt-2.15B $
Net Debt/EBITDA-1.39
Balance Sheet
Debt/Equity—
Current Ratio4.79
Quick Ratio4.12
Book Value/Sh139.98 USD
Cash/Share50.74 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split2:1
Split DateSep 23, 2009
Analyst Consensus
Rating1.6 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)665.46 USD
Upside (mean)+21.6%
Target Range516.00 USD – 750.00 USD
$516.00+21.6% to mean$750.00
# Analysts13
Ownership
Shares Out.42.45M
Float38.92M
Insiders2.04%
Institutions102.13%
Short Interest
Short Ratio4.5d
Short % Float5.66%
Short % Out.4.84%
Shares Short2.05M
Short (prev mo.)2.30M
Technical
SMA 50558.38 (-2.0%)
SMA 200507.06 (+7.9%)
Beta0.58
S&P 52W Chg20.11%
Avg Vol (30d)431.48K
Avg Vol (10d)466.96K
Technical Indicators
RSI (14)47.9
MACD-0.9710
MACD Signal-2.5262
MACD Hist.+1.5552
BB Upper559.07 USD
BB Middle547.01 USD
BB Lower534.95 USD
BB Width4.41%
ATR (14)13.60 USD
Vol Ratio (20d)0.62x